Market Overview
During the most recent 24‑hour window concluding at 05:35 AM Central European Time on Friday, 23 October 2026, the shares of LifeMD, Inc. (ticker LFMD) experienced a decline of 4.89 %. At the close, one share traded at approximately USD 2.17 on major exchanges. The company’s market capitalization stands at USD 108.2 million, while the total available supply of shares is 48.1 million. In the past 24 hours, trading volume for LifeMD was roughly USD 1.3 million.
When viewed over a longer horizon, the stock has fallen 35.15 % since the end of last month. Its 200‑day simple moving average is USD 3.73, indicating that the current price lies well below the medium‑term trend. The most recent 52‑week high reached USD 6.44 on 24 October 2025, whereas the 52‑week low was USD 2.13 on 21 October 2026. These figures illustrate the volatility that has characterized LifeMD’s recent performance.
Peer Performance Snapshot
In the same 24‑hour period, the following peer companies posted the following results:
| Company | Ticker | % Change | Current Price (USD) | Market Capitalisation (USD) | Notes |
|---|---|---|---|---|---|
| Magyar | MGYR | –0.46 % | 19.22 | 125.8 mn | Price‑to‑earnings ratio of 10.54 |
| Owlet | OWLT | –1.87 % | 4.15 | 125.1 mn | |
| Nakamoto | NAKA | +18.28 % | 7.69 | 127.8 mn | |
| Quanterix | QTRX | +2.57 % | 2.84 | 128.6 mn | |
| Outlook Therapeutics | OTLK | +7.88 % | 0.56 | 126.6 mn |
The mixed performance of these contemporaries underscores the sector‑wide uncertainty affecting telehealth and related healthcare technology firms.
Company Profile
LifeMD, Inc. is headquartered in New York, United States, and operates as a direct‑to‑patient telehealth platform. Its services enable patients to connect with licensed providers for virtual diagnoses, care, and prescription medications. In addition to the core platform, LifeMD offers over‑the‑counter products, either as one‑time purchases or through subscription memberships. The company’s online presence is centered at www.lifemd.com , and its shares are listed on the Nasdaq exchange.
This article provides a concise overview of LifeMD’s recent trading activity, contextualizes its performance relative to peer companies, and summarizes key corporate facts relevant to investors and market observers.
